It is widely accepted that the p53 tumor suppressor restricts abnormal cells by induction of growth arrest or by triggering apoptosis. Here we show that, in addition, p53 protects the genome from oxidation by reactive oxygen species (ROS), a major cause of DNA damage and genetic instability. In the absence of severe stresses, relatively low levels of p53 are sufficient for upregulation of several genes with antioxidant products, which is associated with a decrease in intracellular ROS. Downregulation of p53 results in excessive oxidation of DNA, increased mutation rate and karyotype instability, which are prevented by incubation with the antioxidant N-acetylcysteine (NAC). Dietary supplementation with NAC prevented frequent lymphomas characteristic of Trp53-knockout mice, and slowed the growth of lung cancer xenografts deficient in p53. Our results provide a new paradigm for a nonrestrictive tumor suppressor function of p53 and highlight the potential importance of antioxidants in the prophylaxis and treatment of cancer.
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The major function of the p53 tumor suppressor is to restrict abnormal or stress-exposed cells before damage to DNA is converted to inherited mutation 1 . But even without extended stress, the DNA is exposed to endogenous damaging ROS, which are byproducts of normal respiration and are important signaling molecules 2, 3 . Indeed, endogenous ROS are the major source of DNA damage 4 and are a substantial factor contributing to chromosome instability and accumulation of mutations and deletions that may lead to cancer 4, 5 . As the endogenous ROS modify approximately 20,000 bases of DNA per day in a single cell 6 , it is unlikely that the restriction of proliferation of cells with oxidized DNA would be efficient in preventing mutations. Previously it was found that among transcriptional targets of p53 there are several genes whose products potentially generate ROS and whose action presumably contributes to p53-mediated cell death 7, 8 . But other genes whose expression is upregulated by p53, such as glutathione peroxidase 1 (GPX1) 9, 10 , mitochondrial superoxide dismutase 2 (SOD2) 10 and aldehyde dehydrogenase 4 family, member A1 (ALDH4A1) 11 , encode products that would presumably act as antioxidants. In addition, the function of two p53-regulated sestrins, PA26 and Hi95 (encoded by SESN1 and SESN2, respectively), is essential for regeneration of overoxidized peroxiredoxins 12 , the enzymes involved in the decomposition of hydrogen peroxide 3 . These findings suggest that p53 might have opposing roles in the regulation of ROS. Here we distinguish between pro-and antioxidant functions of p53, and identify a substantial contribution of p53-mediated antioxidant mechanisms in the control of genetic stability and prevention of cancer.
RESULTS

Downregulation of p53 elevates intracellular ROS
To show the effects of p53 on ROS levels in nonstressed cells, we inhibited p53 using lentiviral-mediated expression of siRNA in a set of human normal and carcinoma cell lines, all of which have functional p53 ( Supplementary Fig. 1 online) . Analysis of dichlorodihydrofluorescein (DCF) staining showed approximately twofold increases in ROS 48 h after inhibition of p53 (Fig. 1a) . The increase in ROS induced by siRNA to TP53 (which encodes p53 in humans) was similar in magnitude to that observed after treatment of colon carcinomaderived RKO cells with hydrogen peroxide and was completely reversed by incubation with 5 mM N-acetylcysteine (NAC; Supplementary Fig. 2 online) . The expression of TP53-specific siRNA did not notably change growth rate or cell-cycle distribution of RKO cells ( Supplementary Fig. 1 online) and did not increase ROS in the p53-negative cell lines MDAH041 and H1299, similar to empty lentivirus vector or heterologous siRNA to HPV18 E6 gene (Fig. 1b and Supplementary Fig. 2 online) . In contrast, the conditional expression of wild-type p53 from a tetracycline-regulated construct in MDAH041-derived TR9-7 cells 13 resulted in a 50% decrease in ROS ( Supplementary Fig. 2 online) . We also observed the increase in ROS after inhibition of p53 function by other mechanisms, such as overexpression of oncogenic mutant p53 Arg175His, the dominant negative genetic suppressor element of p53 GSE22 (ref. 14) , or the p53 inhibitors HPV16 E6 or MDM2 (Fig. 1c) . A three-to fivefold increase in MDM2 transcripts was sufficient to cause a twofold increase in ROS, whereas in the osteosarcoma cell line U2OS, which is known to bear amplified MDM2 (ref. 15) , the exogenous overexpression of MDM2 did not affect ROS levels ( Supplementary Fig. 3 online) . We also observed a consistent increase in ROS levels in primary lung and spleen fibroblasts and in splenocytes and thymocytes from Trp53-knockout mice compared to wild type mice. (Fig. 1d and Supplementary Fig. 3 online) .
Opposite effects on ROS of different p53 target genes The above observations suggest that p53 may extend its protective function by participating in antioxidant defense. Such activity of p53 should be opposite to the known pro-oxidant function of some stressinduced p53-responsive genes, which may contribute to p53-induced cell death 7, 8 . To estimate the impact of p53-regulated genes with proversus antioxidant products, we overexpressed corresponding cDNAs in RKO and H1299 cells by infection with recombinant lentiviruses and compared intracellular ROS levels 48 h after infection. Although the expression of CDKN1A (also known as P21) did not have any effect, there was an increase in ROS after introduction of the quinone oxidoreductase homolog gene TP53I3 (also known as PIG3), a 2-2.5-fold increase after expression of the proapoptotic gene BBC3 (which encodes Puma), and a 50% decrease in ROS after expression of antioxidant sestrins encoded by SESN2 and SESN1 ( Fig. 2a and Supplementary Fig. 3 online) .
Pro-and antioxidant effects depend on p53 levels We tested how p53 deficiency affects the basal transcription levels of p53-regulated genes. Inhibition of p53 in RKO cells and human embryonic fibroblasts (HEFs) resulted in a notable decrease in SESN2 and a virtual disappearance of GPX1 mRNA and the p53-inducible transcript T2 (ref. 16 ) of SESN1, whereas the levels of genes with pro-oxidant products such as BAX, TP53I3 and BBC3 were undetectable in unstressed cells (Fig. 2b) . Transcription levels of p53-regulated genes differed between organs in mice, reflecting tissue specificity of expression. Where detectable, there was notable decrease in transcripts for the Gpx1 and sestrins in organs of Trp53-knockout mice ( Fig. 2c) , indicating that upregulation of basal transcription of the p53 targets does not represent a cell-culture artifact. To investigate whether the transcription function of p53 is required for the regulation of ROS, we expressed wild-type p53 and the p53 mutant Gln22Leu-Trp23Ser 17 with defective transcription function in p53-negative H1299 and p53-positive RKO cells. To achieve physiological levels of the introduced p53, the expression was driven by a TP53 promoter 18 . Transgene expression after lentiviral introduction develops slowly and reaches its maximum at 55-60 h after infection. By 24 h, the expression level of introduced p53 in H1299 cells was comparable to that in the p53-positive RKO cells; correspondingly, the cells expressing exogenous wild-type p53 showed decreased ROS as compared to control cells ( Fig. 3a and Supplementary Fig. 4 online). At this time point there was notable induction of transcription from SESN1 and CDKN1A. By 48 h we also observed induction of transcripts of the genes with antioxidant products GPX1 and SESN2. By 72 h there was a substantial increase in intracellular ROS, concomitant with apparent overexpression of wild-type p53. These late events coincided with the notable upregulation of TP53I3, BAX and BBC3, and with the induction of apoptosis ( Fig. 3b and Supplementary Fig. 4 online). The Gln22Leu-Trp23Ser p53 mutant induced neither the expression of p53 target genes nor apoptosis. Thus, the p53-dependent changes in ROS rely on transcriptional activation of p53-regulated genes. Considering the role of mitochondria in the release of elevated levels of ROS at late hours after p53 induction 19 , we performed similar experiments in H1299 and RKO r0 cells that lack mitochondrial DNA and are defective for the ROS-generating electrontransport chain 20 ( Fig. 3c and Supplementary Fig. 5 online) . Although prolonged expression of p53 resulted in an approximately twofold increase in ROS in control cells, there was a 50% decrease in ROS in the r0 cells. Introduction of an empty vector or a transcriptionally inactive p53 mutant did not affect ROS levels either in control or in r0 H1299 cells ( Fig. 3d and Supplementary Fig. 5 online) . The pattern and the magnitude of activation of different p53-dependent genes were similar in control and r0 cells ( Supplementary Fig. 5 online) . But the latter were deficient in the production of ROS and showed a substantially (fivefold) attenuated apoptotic response to p53 expression (Fig. 3e) . These results suggest that the p53-dependent increase in ROS originates from mitochondrial leakage during apoptosis. (Fig. 4b,d ). The prooxidant products of the genes TP53I3 and BBC3 were induced at higher concentrations of H 2 O 2 , and the induction of TP53I3 and BBC3 was abrogated in RKO cells with p53 inhibited by siRNA ( Supplementary Figs. 1 and 6 online) . The results suggest that the antioxidant function of p53 is associated with highly responsive p53 target genes that are induced during physiological (nonlethal) stress, whereas the pro-oxidant effect of p53 in gravely damaged cells could be associated with the delayed induction of proapoptotic genes.
p53 deficiency promotes DNA oxidation and mutagenesis The observed increased levels of ROS may contribute to marked genetic instability of TP53-deficient cells. To define the protective role of p53 against DNA oxidation, by avidin-FITC staining we monitored the rate of formation of 8-oxoguanine (8-oxo-dG), the major product of oxidation in DNA, and the major source of mutations. RKO and A549 cells with p53 inhibited by siRNA and Trp53 À/À mouse primary lung fibroblasts showed an increased level of 8-oxo-dG as compared to control cells or Trp53 +/+ mouse primary lung fibroblasts. Staining for 8-oxo-dG also showed a twofold increase in DNA oxidation in spleens of Trp53 À/À mice, confirming that the effects are not related to artificial conditions in cell culture (Fig. 5a,b and Supplementary  Fig. 7 online) . Exogenous overexpression of SESN2 and/or SESN1 in RKO cells with inhibited p53 only partially, though substantially, reversed both the increase in ROS and the excessive DNA oxidation (Fig. 5c,d ), suggesting that sestrins are perhaps not the only mediators of p53-dependent antioxidant function. Oxidative DNA damage is known to be associated with an increased incidence of mutations 4 . Loss of p53 function also results in a mutator phenotype [21] [22] [23] . To test the contribution of p53-modulated antioxidant mechanisms in the protection against mutations, we monitored changes in mutation frequencies within the HPRT gene locus 24 . In RKO cells the number of 6-thioguanine (6-TG)-resistant colonies increased fivefold after inhibition of TP53 and 2.5-fold after inhibition of SESN2 by appropriate siRNAs. Incubation with 5 mM NAC did not affect growth of RKO cells but reversed completely the increase in 6-TG-resistant colonies in RKO cells with p53 inhibited by siRNA; overexpression of SESN2 and SESN1 reduced the number of 6-TGresistant colonies by half ( Fig. 5e and Supplementary Fig. 8 online) . There was no significant increase in 6-TG-resistant colonies after inhibition of CDKN1A, which controls the p53-dependent G1 checkpoint, or after inhibition of proapoptotic BBC3, or after simultaneous inhibition of CDKN1A and BBC3 (Fig. 5f) . A similar increase (fourfold) in mutation rate in the lung carcinoma cell line A549 after inhibition of p53 was also not associated with CDKN1A, whereas inhibition of SESN2 expression substantially increased the number of colonies ( Supplementary Fig. 7 online) . The results indicate that downregulation of p53-modulated genes with antioxidant products strongly contributes to the mutator phenotype of TP53-deficient cells.
p53 deficiency promotes ROS-dependent xenograft growth
We inhibited p53 in lung carcinoma A549 cells by expression of siRNA. When tested in cell culture, there was no change in the growth rate of the cells with inhibited p53, and addition of NAC (up to 3-5 mM) did not affect cell proliferation. But the A549 cells with inhibited p53 showed increased DNA oxidation and increased mutagenesis within the HPRT locus, which was abolished by NAC ( Supplementary Fig. 7 online) . When we injected tumor cells into athymic mice, the p53-deficient A549 cells showed considerable increase in tumor growth rate in comparison with the control A549 cells. Supplementation with NAC did not affect growth of A549 xenografts, whereas there was considerable retardation of growth of p53-deficient A549 xenografts (Fig. 6a) . We observed the same effect using cells with inhibited expression of SESN2, which also showed increased intracellular ROS 12 and increased oxidation of DNA ( Supplementary Fig. 7 online) .
Antioxidant NAC prevents lymphomas in Trp53 À/À mice Trp53-knockout mice develop normally, but succumb to neoplasia (mostly thymic lymphomas) by the age of 6 months 25, 26 . The high tumor incidence is accompanied by a marked genetic instability 27 that includes severe karyotype abnormalities in different organs 28 . We tested the contribution of the elevated ROS to these phenotypes by maintaining Trp53 À/À mice on a NAC-supplemented diet. We added NAC to drinking water starting 2 weeks before mating of Trp53 +/-pairs, and continuing though pregnancy and through the lifetime of Trp53 À/À progeny. The dose of NAC used abolished the difference in ROS levels in splenocytes from wild-type and p53-knockout mice (Fig. 6b) . Karyotype analysis in primary lung fibroblasts of 8-week-old mice maintained on a regular diet showed aneuploidy in most of the cells, with only B15% diploid metaphases, whereas roughly 50% of cells from mice of the same age maintained on the NAC diet had a normal karyotype (Fig. 6c) . By the age of 6 months more than 90% of Trp53 À/À mice had developed malignant tumors, primarily lymphomas, which is consistent with published observations 26, 29 . NAC supplementation had a substantial effect on tumor incidence: out of 25 mice there was not a single case of lymphoma, though there was one case of tumor-free death, two cases of soft-tissue sarcomas and one case of hemangioma at later ages (Fig. 6d) .
DISCUSSION
The functions of the p53 tumor suppressor that restrict proliferation of abnormal cells are activated by stresses, presuming that under normal conditions p53 is dormant. But p53 might have additional functions that do not inhibit cell proliferation but address physiological stresses, which produce repairable injuries. One of the emerging protective functions of p53 is the enhancement of DNA repair [30] [31] [32] . We show that, in addition, p53 downregulates intracellular ROS levels, thus reducing the probability of genetic alterations. The antioxidant function of p53 was not expected, as p53 is known as a potent prooxidant protein, inducing a set of ROS-generating gene products that contribute to apoptosis 8 . We show that the pro-oxidant function of p53 is tightly linked to release of mitochondrial ROS during stressinduced apoptosis. But the antioxidant function of p53 is mediated through a set of antioxidant gene products, which are responsive to lower levels of p53 in nonstressed or physiologically stressed cells. We propose that the antioxidant function of p53 represents an important component of its tumor suppressor activity, which decreases the probability of genetic alterations and assists the survival and repair of cells with minor injuries. We showed the potential contribution of p53-dependent antioxidant mechanisms in tumor suppression in the lung carcinoma cell line A549 xenograft model. The substantial acceleration in tumor development after inhibition of p53 was reversed by NAC supplementation, although there was no effect of NAC on xenograft growth rate with control A549 cells. The increased oxidation of DNA and increased mutation rate within the HPRT locus in p53-inhibited cells suggest that the increased tumor growth could be related to elevated genetic instability and accelerated tumor progression. Notably, we observed a similar NAC-sensitive increase in xenograft growth after inhibition of SESN2, which also results in elevated intracellular ROS and DNA oxidation. The result suggests that other genetic conditions leading to compromised antioxidant defense might also induce genetic instability and contribute to malignant progression. We found that the increased intracellular ROS in p53-deficient mice contributes substantially to the cancer-prone phenotype. Previously it was found that disruption of the p53 target genes CDKN1A, which is essential for cell-cycle arrest, and BBC3, which is an obligatory component of p53-dependent apoptosis 21 , produces no significant increase in tumor frequency [33] [34] [35] . In contrast, a calorie-restricted diet, which is known to be associated with decreased ROS 35 and low oxidation of DNA 7 , increases the latency of spontaneous tumor development in Trp53 À/À mice 38, 39 . We show that dietary supplementation with NAC substantially reduces the incidence of tumors, especially the development of thymic lymphomas, which are the predominant malignancy in Trp53 À/À mice. Certainly, the increased mutation rate associated with excessive oxidation to DNA in p53-deficient cells might contribute to the early development of lymphomas. In addition, we found a substantial reduction in karyotype abnormalities in tissues of Trp53 À/À mice maintained on a NAC diet. The observed antitumor effect of NAC might be related to overall improvement of genetic stability associated with decreased intracellular ROS. Accumulation of aneuploid cells among p53-deficient cells was earlier shown to be a result of increased frequency of abnormal mitoses 40 , whereas reintroduction of functional p53 restricts growth of polyploid cell 41 . These observations suggest that p53 controls karyotype stability not only through restriction of cells with abnormal mitoses, but also by reducing the incidence of the latter. The increased intracellular ROS in p53-deficient cells might alone affect adversely the coordinate chromosome segregation leading to deterioration of karyotype. Recently a mutator phenotype associated with increased genomic deletions in Atm À/À mice was found to be reversed by dietary supplementation with NAC 42 . Similar to the Trp53 À/À mice, the Atm À/À mice show increased 8-oxo-dG levels and develop early thymic lymphomas 43 , which are suppressed by an antioxidant 44 . In these mouse models, the increased intracellular ROS might be a common cause for frequent genetic alterations and lymphomas.
Inherited deficiency in p53, which is associated with either heterozygous germline mutations within TP53 (Li-Fraumeni syndrome 45, 46 ) or upregulation of MDM2 from a polymorphic allele 47 leads to early development of cancer. We found that similar to inhibition of p53 by genomic knockout or siRNA, both introduction of mutant p53 and overexpression of MDM2 are associated with increased intracellular ROS and increased mutation rates. We suggest that genetic alterations associated with elevated ROS might substantially contribute to the earlier onset of tumors in individuals with Li-Fraumeni syndrome or in individuals with the polymorphous MDM2 allele. NAC or similar antioxidants could be found effective as prophylactic compounds for prevention of cancer in individuals with these and other inherited deficiencies within the p53 pathway. Likewise, inactivation of p53, which is common in malignant cells, can promote oxidation-mediated mutagenesis, contributing to accelerated malignant progression. Our results showing selective inhibition of p53-deficient xenograft growth by NAC supplementation suggest that the introduction of antioxidants to cancer therapy schemes might improve genetic stability of p53-deficient tumor cells and retard cancer progression.
METHODS
Cell culture. We cultured human colon carcinoma cell lines RKO and LIM1215, lung carcinoma lines H1299 and A549, osteosarcoma line U2OS, normal foreskin fibroblast line BJ, normal lung fibroblast lines WI-38, MRC5 and IMR90, fibroblasts from a 12-week human embryo, passage 10-14 HEFs obtained from the Englehardt Institute of Molecular Biology cell culture collection and skin fibroblasts from an individual with Li-Fraumeni syndrome (line MDAH041) in DMEM supplemented with 10% FBS (Hyclone). We maintained the MDAH041 derivatives with conditional expression of wild-type p53 (TR9-7 cells) 13 in the presence of 2 mg/ml of tetracycline to suppress expression of p53. We isolated mouse lung and spleen fibroblasts, splenocytes and thymocytes from C57Black wild-type and p53-knockout mice 29 . We obtained mitochondrial DNA-deficient (r0) H1299 and RKO cells and cultured them as described 20 . We monitored functional mitochondria in control and r0 cells with MitoTracker Red 589 (Molecular Probes).
Western analyses. We performed western analyses as previously described 12 .
For detection of p53, we used DO1 antibodies (Santa Cruz Biotech), diluted 1:2,000.
Mutation frequency within HPRT locus. We determined the mutation frequency within the HPRT locus by counting 6-TG-resistant colonies 22 . The RKO and A549 cells were preselected on the medium containing hypoxanthine, aminopterine and thymidine (HAT; Sigma). After infection with corresponding recombinant lentiviruses, we grew RKO or A549 cells exponentially for 2 weeks to allow accumulation of mutations. We seeded the cells at 2Â10 5 cells per plate in the medium containing 40-80 mg/ml of 6-TG and scored the number of colonies after 18 d. To study the contribution of elevated ROS to mutation frequency, we maintained the cells in medium containing 5 mM NAC immediately after the infection with TP53-specific siRNA lentivirus.
Animal studies. The Englehardt Institute of Molecular Biology Ethical Committee approved all animal studies, and animal care was in accordance with the Russian Academy of Sciences and US National Institutes of Health guidelines. For tumorigenesis assay in athymic mice, we subcutaneously injected 5 Â 10 5 A549 cells (control and with p53 inhibited by expression of siRNA) into athymic nu/nu mice. A group of mice was supplemented with 40 mM NAC in drinking water. We measured tumor volume every 3 d. For spontaneous tumor frequency assay, we maintained families of Trp53 +/-mice 47 (C57Black background) on regular diet or diet supplemented with 40 mM NAC (SigmaAldrich) added to drinking water 49 to yield an average dose of 1 g NAC per kg body weight per day. We maintained the Trp53 À/À progeny with or without NAC supplementation throughout their lifetimes. We monitored formation of tumors by daily inspection and confirmed tumors by histological examination.
Karyotype analysis. We incubated primary lung fibroblasts from 8-week-old Trp53 À/À mice with 0.1 mg/ml colcemid at day 6 in tissue culture and performed cytogenetic analysis after Giemsa staining. To determine the frequency of aneuploid cells, we karyotyped 500 metaphases per sample in cultures derived from three pairs of mice.
Note: Supplementary information is available on the Nature Medicine website.
